“showed a trend”

The MRS data showed a trend of NAD + remaining stable or decreasing slightly in Young hearts with higher workload but increasing in Old Control hearts ( p = 0.066) (Figure 4e ).

Intestinal Electrophysiology in the Jejunum, Short-Chain Fatty Acid Concentration, and pH along the Intestinal Tract The jejunal electrophysiological parameters showed a trend for a decrease in the basal I SC due to the LA-treated cereals ( Table 2 ; p = 0.066) before the addition of Na 2 HPO 4 .

In the multivariate Cox’s regression analysis (adjusted to patient’s tumor stage, lymph node status (N-stage) and tumor grade), a high CAIX protein level in the tumor showed a trend of significance for an increased risk of death (RR = 1.7; p = 0.066) compared to patients with a low CAIX protein level in their tumor ( Table 2 , Figure 5 ).

25.6%; p = 0.592), while alcohol consumption showed a trend toward a different distribution (χ 2 = 7.20, df = 3, p = 0.066), with a notably higher proportion of non-drinkers in the rosacea group (26.3% vs. 8.2%).

Patients with accessory spleen showed a trend towards older age at initiation of rituximab compared to the other group (median 51 (range 43–75 years) and 42.5 (range 30–60 years), respectively; p = 0.066).

In the entire study cohort, patients undergoing POCRT showed a trend toward higher locoregional control (LRC) rates than those treated with PORT alone at both 5 and 8 years (97 and 97 % versus 84 and 79 %, respectively; P = .066).

Clinicopathological Comparison Between nPD-L1 Positivity and Negativity In our study, the nPD-L1-positive group showed a trend toward an older median age (48 y vs 42 y, p=0.066) and higher PINK score (45.4% vs 37.8%, p=0.071) and a trend toward a lower CR rate after initial treatment (47.7% vs 67.6%, p=0.073) ( Table 2 ).

The results implied that the ablation group showed a trend toward reduction of ES compared to medical therapy (Mantel-Haenszel pooled relative risk 0.61, P = 0.066).

Consistent with the pressure–volume loop data, echocardiography data showed a trend ( P = 0.066) for an increased FS when compared to intermittent air mice.

While ABCG2 (12M/141Q) conferred the highest resistance among the tested variants, the ABCG2 (12M/141K) haplotype showed a trend toward higher mitoxantrone resistance than the ABCG2 (12V/141Q) (WT) ( p = 0.066), suggesting a haplotype-specific effect.

Locoregional recurrence showed a trend toward reduction (3.8% [5/132] vs. 9.4% [31/330], p = 0.066), whereas distant metastasis and overall mortality were similar between groups. 3.4.

In contrast, although no statistically significant difference was observed, the correlation between sSDC1 and TG levels showed a trend toward a positive correlation in patients (ρ = 0.114, p = 0.066).

Age showed a trend‐level association (β = 0.19, p = 0.066), while sex was not related to c (β = −0.12, p = 0.28).

Woebot participants showed a trend toward improvement [t(33) = −1.55, p = .066, one-tailed], and Tinnibot participants showed a statistically significant increase [t(35) = −1.72, p = .047, one-tailed], consistent with hypothesised effects Given the absence of a significant interaction.

4 ), the MSD group showed a trend toward inferior OS ( p = 0.066) and RFS ( p = 0.052) compared with the alternative donor group, accompanied by a higher relapse rate ( p = 0.003).

Only the occurrence of RT stenosis or TEF showed a trend towards poor LFFS in multivariate analysis ( P = 0.066) (Supplementary Table 3 and Figure 1A ).

In contrast, HPTR1 expression varied significantly with patient age ( p = 0.020) and showed a trend with metabolic status ( p = 0.066) and sex ( p = 0.056).

Univariate analysis showed a trend toward higher recurrence rates in females ( p = 0.066), advanced pN stage ( p = 0.1) and in cases with perineural invasion ( p = 0.095), without reaching statistical significance (Table 4 ).

Patients who progressed from PET imaging onwards showed a trend toward more rBRLs ( P = 0.066; Extended Data Fig. 8h,i ).

At 6-month follow-up, patients with signs of metabolic syndrome showed a trend towards lower PHES compared to patients without these manifestations (− 6.3 ± 1.2 vs. − 3.6 ± 0.6; 95CI = − 0.2–5.6; p = 0.066).

Patients with disease activity higher than the median at golimumab initiation showed a trend to lower retention (p=0.066).

We found that 5 μM colibactin 742 showed a trend toward reduced proliferation in NTC cells ( P = 0.0661) but not PSMD4 −/− cells ( P = 0.9462), and that the proportion of BrdU cells was significantly higher in PSMD4 −/− cells after 1 μM ( P < 0.0001) and 5 μM ( P = 0.0078) colibactin treatment ( Fig.

However, HNSCC patients with advanced stages (stages III and IV) showed a trend towards lower levels of plasma NE (p = .0662).

Furthermore, the expression levels (median signal intensity, MSI) of CD57, a marker for terminal differentiation, among CD8 TEMRA showed a trend to be increased ( p = 0.0663) in PD (Fig. 1g ).

Despite their considerable melanoma cell expansion, MeWo-RhS only showed a trend towards an increase in M-CSF secretion ( p = 0.0664), compared to the RhS control ( Figure 2 b).